The effects of debrisoquin and bretylium on adrenergic nerves as revealed by fluorescence histochemistry.
D000578:Amidines / Q000494:pharmacology*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001949:Bretylium Compounds / Q000494:pharmacology*; D003891:Desipramine / Q000494:pharmacology; D005453:Fluorescence; D006651:Histocytochemistry; D007498:Iris / Q000187:drug effects / Q000378:metabolism; D007546:Isoquinolines / Q000494:pharmacology*; D008781:Methyltyrosines / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D009647:Normetanephrine / Q000378:metabolism; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000187:drug effects*; D009435:Synaptic Transmission / Q000187:drug effects; D014316:Tritium
D000578:Amidines; D000959:Antihypertensive Agents; D001949:Bretylium Compounds; D007546:Isoquinolines; D008781:Methyltyrosines; D009647:Normetanephrine; D014316:Tritium; D012110:Reserpine; D009526:Nialamide; D003891:Desipramine; D009638:Norepinephrine